Europe Ultrasound Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the Europe ultrasound devices market size is estimated at USD 3.14 billion in 2026, and is expected to reach USD 4.06 billion by 2031, at a CAGR of 5.29% during the forecast period (2026-2031).

This report is Segmented by Application (Radiology & General Imaging, and More), Technology (2D Ultrasound Imaging, 3D & 4D Ultrasound Imaging, and More), Device Portability (Cart/Trolley-based, Compact Portable, Handheld/Wireless), End User (Hospitals, and More), and Geography (Germany, UK, France, Italy, Spain, Rest of Europe). The Market Forecasts are Provided in Terms of Value (USD).

Europe Ultrasound Devices Market Trends and Insights

Increased Adoption of Diagnostic Imaging in Primary Care

Primary-care physicians across Western Europe are equipping surgeries with handheld or laptop ultrasound devices to shorten referral queues and triage non-urgent complaints on-site. Germany already has 98% penetration in general practices, setting a reference model for neighboring health systems. The United Kingdom's Integrated Diagnostics and Pathology framework is placing portable scanners in 155 Community Diagnostic Centres, allowing musculoskeletal and abdominal scans to be completed outside hospitals, thereby relieving pressure on radiology departments. Eastern Europe remains behind the curve because budgets and reimbursement codes still favor hospital-centric imaging. Whether ministries adjust tariff schedules for primary-care scans will determine how quickly adoption spreads to that region.

Growing Burden of Chronic Diseases

Cardiovascular disease continues to cause 45% of all European deaths, which in turn generates steady demand for repeat echocardiography and Doppler studies to monitor heart-failure progression. Oncology pathways increasingly rely on ultrasound-guided needle biopsies and contrast-enhanced exams for real-time characterization of liver and kidney tumors, enabling clinicians to avoid radiation-based CT when diagnostic performance is equal. Diabetes complications prompt vascular screening that identifies peripheral artery disease earlier, thereby expanding the overall pool of patients examined. Because each chronic patient now undergoes multiple imaging events per year, utilization rates rise even though the continent's population is aging rather than growing. Portable probes are well-suited for at-home monitoring and community follow-up visits, which outpace stationary installations in hospitals.

Fragmented Reimbursement for Handheld Devices

Most European tariff systems were designed for hospital radiology, so a handheld abdominal scan in a community clinic can be reimbursed at 30-50% below the equivalent cart-based code, or not reimbursed at all. NICE endorsed point-of-care ultrasound in emergency departments in 2024, yet NHS billing tables have not been updated, forcing trusts to either absorb the cost or restrict its deployment. France and Spain maintain dual fee schedules that pay radiologist-performed exams significantly more than clinician-performed studies, limiting the uptake of handheld devices beyond urban hospitals. Eastern European funds are even tighter, and payers often refuse coverage for any ultrasound conducted outside a radiology department, curbing handheld adoption where it might otherwise offset sonographer shortages.

Other drivers and restraints analyzed in the detailed report include:

1. Miniaturization and Point-of-Care Uptake in Ambulances and Home-Care
2. AI-Enabled Workflow Efficiencies Reducing Exam Time
3. Shortage of Certified Sonographers Across Eastern Europe

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, radiology and general imaging maintained a 24.31% share of the European ultrasound devices market, thanks to their entrenched workloads in hospital departments, including abdominal, soft-tissue, and vascular imaging. However, obstetrics and gynecology are scaling fastest at a 7.48% CAGR because national prenatal protocols now recommend three to four scans per pregnancy and add 3D/4D imaging for anomaly detection. The European ultrasound devices market size tied to obstetric endpoints is therefore rising more quickly than radiology volumes, especially in Spain and Italy, where maternal screening investments are part of post-pandemic recovery budgets. A simultaneous surge in cardiac Doppler and echocardiography is driven by heart-failure monitoring: cardiovascular disease causes 45% of European deaths, and each case necessitates serial imaging. Emergency and critical-care teams accelerate uptake of FAST protocols, while musculoskeletal clinics deploy high-frequency probes as cheaper, faster alternatives to MRI for tendon tears.

Clinical diversification broadens revenue streams because every incremental application requires at least one dedicated transducer. This momentum benefits vendors that offer modular platforms flexible enough to support obstetrics, vascular and anesthesiology workflows on the same console. Conversely, radiology growth is capped by staff shortages, creating a ceiling on the number of additional exams that hospital departments can absorb. Portable scanners further tilt share toward obstetrics because prenatal visits often occur in outpatient settings where mobility is prized.

Three-dimensional and four-dimensional imaging captured 44.73% of the European ultrasound devices market size in 2025, owing to its dominance in fetal, breast, and musculoskeletal use cases. Vendors refine algorithms that render lifelike fetal images within seconds, deepening demand among expectant parents and clinicians. At the same time, HIFU is expanding at a 7.97% CAGR by offering a non-invasive alternative for uterine fibroid and prostate cancer ablation, reducing hospitalization and surgical risk. Doppler modalities remain essential for vascular assessments, whereas elastography is emerging as a preferred non-invasive method to stage liver fibrosis, aligning with EASL practice guidelines.

As reimbursement agencies increasingly cover therapeutic ultrasound, vendors are packaging diagnostic and ablative capabilities on the same platform, thereby elevating average selling prices. European notified bodies nevertheless demand robust safety data for each indication, lengthening the time to market. Vendors capable of bundling 3D/4D, Doppler, elastography, and HIFU on a unified upgradeable architecture stand to maximize replacement-cycle sales as hospitals streamline fleets.

Complete Report Scope:

• By Application
  • Radiology & General Imaging
  • Obstetrics & Gynecology
  • Cardiology
  • Emergency & Critical Care
  • Musculoskeletal
  • Anesthesiology
  • Other Applications
• By Technology
  • 2D Ultrasound Imaging
  • 3D & 4D Ultrasound Imaging
  • Doppler Imaging
  • High-Intensity Focused Ultrasound (HIFU)
  • Elastography
  • Contrast-Enhanced Ultrasound (CEUS)
• By Device Portability
  • Cart / Trolley-based
  • Compact Portable
  • Handheld / Wireless
• By End User
  • Hospitals
  • Diagnostic Imaging Centres
  • Ambulatory Surgical Centres
  • Home Healthcare Settings
• By Country
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe

List of Companies Covered in this Report:

1. Alpinion Medical Systems
2. Analogic Corp.
3. Butterfly Network
4. Canon
5. CHISON Medical Imaging
6. Clarius Mobile Health
7. EDAN Instruments
8. Esaote
9. FUJIFILM
10. GE Healthcare
11. Hitachi Medical Systems Europe
12. Konica Minolta Healthcare
13. Koninklijke Philips
14. Mindray
15. Samsung Group
16. Shenzhen VINNO
17. Siemens Healthineers
18. Sonoscanner
19. Telemed Medical Systems
20. Terason

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support